Laboratory Diagnostic Approach and Interpretation in Gram-Negative Bacterial Infection: A-Case Report of Sepsis in Secondary Hospital Settings

Adhi Kristianto Sugianli, Ida Parwati

Abstract


Gram-Negative Bacteria (GNB) have been widely reported to cause worldwide infections and life-threatening. The high prevalence of drug-resistant GNB causes the treatment of GNB to become difficult. This case report describes a stepwise laboratory approach and interpretation for Gram-negative bacteria infection in sepsis patients. An 84-year-old female patient with a history of congestive heart failure, after three weeks of hospitalization, GNB was proven as the cause of sepsis. Laboratory approach for inflammation (C-reactive protein, procalcitonin) was made and confirmed with a positive culture of several specimens (sputum, urine, and blood). The identification of bacterial-culture revealed as Carbapenem-resistance Klebsiella pneumoniae and Extended-spectrum Beta-lactamases Escherichia coli. This case highlights GNB as a potential agent to worsen the infection (sepsis) and also a useful approach for the detection of multidrug-resistant bacteria, particularly in secondary hospital settings. The application and interpretation of integrated clinical and laboratory criteria may bring out better and effective patient management.


Keywords


Drug-resistant microbes, Gram-negative bacteria, sepsis laboratory diagnostic

Full Text:

PDF

References


Heesterbeek DAC, Martin NI, Velthuizen A, Duijst M, Ruyken M, Wubbolts R, et al. Complement-dependent outer membrane perturbation sensitizes Gram-negative bacteria to Gram-positive specific antibiotics. Sci Rep. 2019 Dec;9(1).

Martin RM, Bachman MA. Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae. Front Cell Infect Microbiol. 2018 Jan 22;8.

Forget P, Khalifa C, Defour J-P, Latinne D, Van Pel M-C, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017 Dec;10(1).

Ljungström L, Pernestig A-K, Jacobsson G, Andersson R, Usener B, Tilevik D. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. Azevedo LCP, editor. PLOS ONE. 2017 Jul 20;12(7):e0181704.

Fraenkel PG. Anemia of Inflammation. Med Clin North Am. 2017 Mar;101(2):285–96.

Onyenekwu CP, Okwundu CI, Ochodo EA. Procalcitonin, C-reactive protein, and presepsin for the diagnosis of sepsis in adults and children. Cochrane Emergency and Critical Care Group, editor. Cochrane Database Syst Rev. 2017 Apr 5; Available from: http://doi.wiley.com/10.1002/14651858.CD012627

Korean Shock Society (KoSS) Investigators, Ryoo SM, Han KS, Ahn S, Shin TG, Hwang SY, et al. The usefulness of C-reactive protein and procalcitonin to predict prognosis in septic shock patients: A multicenter prospective registry-based observational study. Sci Rep. 2019 Dec;9(1).

Yamaguti I, Uki N, Ikeda H, Kawasaki S, Nagasawa Z, Ohta S, et al. About the Usefulness of the Urinary Tract Infection Screening Using UX-2000. Sysmex J Int. 2013;23(1):6.

Yasutake Y, Higuchi M, Oda S, Tamura Y, Shimadu T, Kobayashi H, et al. Comparisons of the Bact Scattergram Pattern by Fully Automated Integrated Urine Analyzer UX-2000 and Microscopic Examination Results Using Gram Stain. Sysmex J Int. 2013;23(1):10.

Vandepitte J, World Health Organization, editors. Basic laboratory procedures in clinical bacteriology. 2nd ed. Geneva: World Health Organization; 2003. 167 p.

German G, Gilmour M, Tipples G, Adam H, Almohri H, Bullard J, et al. Canadian recommendations for laboratory interpretation of multiple or extensive drug resistance in clinical isolates of Enterobacteriaceae, Acinetobacter species and Pseudomonas aeruginosa. Can Commun Dis Rep. 2018 Jan 4;44(01):29–34.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801.

Ginting F, Sugianli AK, Kusumawati RL, Parwati I, de Jong MD, Schultsz C, et al. Predictive value of the urinary dipstick test in the management of patients with urinary tract infection-associated symptoms in primary care in Indonesia: a cross-sectional study. BMJ Open. 2018;8(8):e023051.

De Rosa R, Grosso S, Lorenzi G, Bruschetta G, Camporese A. Evaluation of the new Sysmex UF-5000 fluorescence flow cytometry analyser for ruling out bacterial urinary tract infection and for prediction of Gram negative bacteria in urine cultures. Clin Chim Acta. 2018 Sep;484:171–8.

Yang C-C, Chang S-J, Yang SS-D, Lin C-D, Peng C-H. Rapid diagnosis of uncomplicated urinary tract infection with laser flow cytometry. Urol Sci. 2016 Sep;27(3):135–9.

Jefferson B Mendoza VVA. Predict Urinary Tract Infection and to Estimate Causative Bacterial Class in a Philippine Subspecialty Hospital. J Nephrol Ther. 2015;05(02).

Geerts N, Jansz AR, Boonen KJM, Wijn RPWF, Koldewijn EL, Boer AK, et al. Urine flow cytometry can rule out urinary tract infection, but cannot identify bacterial morphologies correctly. Clin Chim Acta. 2015 Aug;448:86–90.

Ozawa H, Yajima N, Kobayashi H. Estimation of the Causative Bacterial Group from Bacterial Scattergrams of the Fully Automated Urine Particle Analyzer UF-1000i. Sysmex J Int. 2012;22(1):6.

Sugianli AK, Parwati I, Rachmayati S. Combination of quantitative bacterial and WBC count from urine flow cytometry to estimate the success of urine culture in symptomatic urinary tract infections. Malays J Microbiol. 2017;13:7.

Sánchez-García JM, Sorlózano-Puerto A, Navarro-Marí JM, Gutiérrez Fernández J. Evolution of the antibiotic-resistance of microorganisms causing urinary tract infections: A 4-year epidemiological surveillance study in a hospital population. Rev Clínica Esp Engl Ed. 2019 Apr;219(3):116–23.

Sugianli AK, Ginting F, Kusumawati RL, Pranggono EH, Pasaribu AP, Gronthoud F, et al. Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia. J Antimicrob Chemother. 2017;72:1469–77.

San Millan A. Evolution of Plasmid-Mediated Antibiotic Resistance in the Clinical Context. Trends Microbiol. 2018 Dec;26(12):978–85.




DOI: http://dx.doi.org/10.24293/ijcpml.v26i3.1563

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.